-
1
-
-
70049098967
-
Spontaneous reattachment of the margins of a macular retinal pigment epithelium tear: Optical coherence tomography documentation of a case
-
Pece A, Vitale L, Milani P, Pierro L. Spontaneous reattachment of the margins of a macular retinal pigment epithelium tear: Optical coherence tomography documentation of a case. Ophthalmologica. 2010;224(3): 159-161.
-
(2010)
Ophthalmologica.
, vol.224
, Issue.3
, pp. 159-161
-
-
Pece, A.1
Vitale, L.2
Milani, P.3
Pierro, L.4
-
2
-
-
84866563306
-
Vascularized retinal pigment epithelial detachment in age-related macular degeneration: Treatment and RPE tear incidence
-
Introini U, Torres Gimeno A, Scotti F, Setaccioli M, Giatsidis S, Bandello F. Vascularized retinal pigment epithelial detachment in age-related macular degeneration: treatment and RPE tear incidence. Graefes Arch Clin Exp Ophthalmol. 2012;250(9):1283-1292.
-
(2012)
Graefes Arch Clin Exp Ophthalmol.
, vol.250
, Issue.9
, pp. 1283-1292
-
-
Introini, U.1
Torres Gimeno, A.2
Scotti, F.3
Setaccioli, M.4
Giatsidis, S.5
Bandello, F.6
-
3
-
-
67349252496
-
One-year results of combined photodynamic therapy and intravitreal bevacizumab injection for retinal pigment epithelial detachment secondary to age-related macular degeneration
-
Shima C, Gomi F, Sawa M, Sakaguchi H, Tsujikawa M, Tano Y. One-year results of combined photodynamic therapy and intravitreal bevacizumab injection for retinal pigment epithelial detachment secondary to age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol. 2009;247(7):899-906.
-
(2009)
Graefes Arch Clin Exp Ophthalmol.
, vol.247
, Issue.7
, pp. 899-906
-
-
Shima, C.1
Gomi, F.2
Sawa, M.3
Sakaguchi, H.4
Tsujikawa, M.5
Tano, Y.6
-
4
-
-
84858067041
-
The importance of informed consent in patients with wet age-related macular degeneration considering intravitreal anti-vascular endothelial growth factor treatments
-
McLaughlin S, Lockington D, Mansfield D. The importance of informed consent in patients with wet age-related macular degeneration considering intravitreal anti-vascular endothelial growth factor treatments. Scott Med J. 2012;57(1):48-49.
-
(2012)
Scott Med J.
, vol.57
, Issue.1
, pp. 48-49
-
-
McLaughlin, S.1
Lockington, D.2
Mansfield, D.3
-
5
-
-
34250181354
-
Retinal pigment epithelial tears after intravitreal bevacizumab injection for neovascular age-related macular degeneration
-
Chan CK, Meyer CH, Gross JG, et al. Retinal pigment epithelial tears after intravitreal bevacizumab injection for neovascular age-related macular degeneration. Retina. 2007;27(5):541-551.
-
(2007)
Retina.
, vol.27
, Issue.5
, pp. 541-551
-
-
Chan, C.K.1
Meyer, C.H.2
Gross, J.G.3
-
6
-
-
82755182750
-
Incidence of retinal pigment epithelial tears after intravitreal ranibizumab injection for neovascular age-related macular degeneration
-
Cunningham ET Jr, Feiner L, Chung C, Tuomi L, Ehrlich JS. Incidence of retinal pigment epithelial tears after intravitreal ranibizumab injection for neovascular age-related macular degeneration. Ophthalmology. 2011; 118(12):2447-2452.
-
(2011)
Ophthalmology.
, vol.118
, Issue.12
, pp. 2447-2452
-
-
Cunningham Jr., E.T.1
Feiner, L.2
Chung, C.3
Tuomi, L.4
Ehrlich, J.S.5
-
7
-
-
34547786670
-
RPE-rip after intravitreal bevacizumab (Avastin) treatment for vascularised pigment epithelial detachment secondary to AMD
-
Gamulescu MA, Framme C, Sachs H. RPE-rip after intravitreal bevacizumab (Avastin) treatment for vascularised pigment epithelial detachment secondary to AMD. Graefes Arch Clin Exp Ophthalmol. 2007;245(7):1037-1040.
-
(2007)
Graefes Arch Clin Exp Ophthalmol.
, vol.245
, Issue.7
, pp. 1037-1040
-
-
Gamulescu, M.A.1
Framme, C.2
Sachs, H.3
-
8
-
-
84894456852
-
Additional anti-vascular endothelial growth factor therapy for eyes with a retinal pigment epithelial tear after the initial therapy
-
Asao K, Gomi F, Sawa M, Nishida K. Additional anti-vascular endothelial growth factor therapy for eyes with a retinal pigment epithelial tear after the initial therapy. Retina. 2014;34(3):512-518.
-
(2014)
Retina.
, vol.34
, Issue.3
, pp. 512-518
-
-
Asao, K.1
Gomi, F.2
Sawa, M.3
Nishida, K.4
-
9
-
-
67749106387
-
Tachyphylaxis after intravitreal bevacizumab for exudative age-related macular degeneration
-
Forooghian F, Cukras C, Meyerle CB, Chew EY, Wong WT. Tachyphylaxis after intravitreal bevacizumab for exudative age-related macular degeneration. Retina. 2009;29(6):723-731.
-
(2009)
Retina.
, vol.29
, Issue.6
, pp. 723-731
-
-
Forooghian, F.1
Cukras, C.2
Meyerle, C.B.3
Chew, E.Y.4
Wong, W.T.5
-
10
-
-
56549111386
-
Is there tachyphylaxis to intravitreal anti-vascular endothelial growth factor pharmacotherapy in age-related macular degeneration?
-
Schaal S, Kaplan HJ, Tezel TH. Is there tachyphylaxis to intravitreal anti-vascular endothelial growth factor pharmacotherapy in age-related macular degeneration? Ophthalmology. 2008;115(12):2199-2205.
-
(2008)
Ophthalmology.
, vol.115
, Issue.12
, pp. 2199-2205
-
-
Schaal, S.1
Kaplan, H.J.2
Tezel, T.H.3
-
11
-
-
84883740682
-
Visual and anatomical outcomes of intravitreal aflibercept in eyes with persistent subfoveal fluid despite previous treatments with ranibizumab in patients with neovascular age-related macular degeneration
-
Kumar N, Marsiglia M, Mrejen S, Fung AT. Visual and anatomical outcomes of intravitreal aflibercept in eyes with persistent subfoveal fluid despite previous treatments with ranibizumab in patients with neovascular age-related macular degeneration. Retina. 2013;33(8): 1605-1612.
-
(2013)
Retina.
, vol.33
, Issue.8
, pp. 1605-1612
-
-
Kumar, N.1
Marsiglia, M.2
Mrejen, S.3
Fung, A.T.4
-
12
-
-
84879209123
-
Short-term outcomes of aflibercept for neovascular age-related macular degeneration in eyes previously treated with other vascular endothelial growth factor inhibitors
-
Ho VY, Yeh S, Olsen TW, et al. Short-term outcomes of aflibercept for neovascular age-related macular degeneration in eyes previously treated with other vascular endothelial growth factor inhibitors. Am J Ophthalmol. 2013;156(1):23-28.
-
(2013)
Am J Ophthalmol.
, vol.156
, Issue.1
, pp. 23-28
-
-
Ho, V.Y.1
Yeh, S.2
Olsen, T.W.3
-
13
-
-
84866370357
-
Aflibercept for age-related macular degeneration: A game-changer or quiet addition?
-
Browning DJ, Kaiser PK, Rosenfeld PJ, Stewart MW. Aflibercept for age-related macular degeneration: a game-changer or quiet addition? Am J Ophthalmol. 2012;154(2):222-226.
-
(2012)
Am J Ophthalmol.
, vol.154
, Issue.2
, pp. 222-226
-
-
Browning, D.J.1
Kaiser, P.K.2
Rosenfeld, P.J.3
Stewart, M.W.4
-
14
-
-
84865129521
-
Binding and neutralization of vascular endothelial growth factor (VEGF) and related ligands by VEGF Trap, ranibizumab and bevacizumab
-
Papadopoulos N, Martin J, Ruan Q, et al. Binding and neutralization of vascular endothelial growth factor (VEGF) and related ligands by VEGF Trap, ranibizumab and bevacizumab. Angiogenesis. 2012;15(2): 171-185.
-
(2012)
Angiogenesis.
, vol.15
, Issue.2
, pp. 171-185
-
-
Papadopoulos, N.1
Martin, J.2
Ruan, Q.3
-
15
-
-
0037143764
-
VEGF-Trap: A VEGF blocker with potent antitumor effects
-
Holash J, Davis S, Papadopoulos N, et al. VEGF-Trap: a VEGF blocker with potent antitumor effects. Proc Natl Acad Sci U S A. 2002;99(17): 11393-11398.
-
(2002)
Proc Natl Acad Sci U S A.
, vol.99
, Issue.17
, pp. 11393-11398
-
-
Holash, J.1
Davis, S.2
Papadopoulos, N.3
-
16
-
-
43649083100
-
Predicted biological activity of intravitreal VEGF Trap
-
Stewart MW, Rosenfeld PJ. Predicted biological activity of intravitreal VEGF Trap. Br J Ophthalmol. 2008;92(5):667-668.
-
(2008)
Br J Ophthalmol.
, vol.92
, Issue.5
, pp. 667-668
-
-
Stewart, M.W.1
Rosenfeld, P.J.2
-
17
-
-
84877665569
-
Rapid response of retinal pigment epithelial detachments to intravitreal aflibercept in neovascular age-related macular degeneration refractory to bevacizumab and ranibizumab
-
Patel KH, Chow CC, Rathod R, et al. Rapid response of retinal pigment epithelial detachments to intravitreal aflibercept in neovascular age-related macular degeneration refractory to bevacizumab and ranibizumab. Eye (Lond). 2013;27(5):663-667.
-
(2013)
Eye (Lond).
, vol.27
, Issue.5
, pp. 663-667
-
-
Patel, K.H.1
Chow, C.C.2
Rathod, R.3
|